A phase 1 comparative pharmacokinetic and cardiac safety study of two intravenous formulations of CO-101 in patients with advanced solid tumors.

More about this publication

Journal of clinical pharmacology
  • Volume 53
  • Issue nr. 8
  • Pages 878-83
  • Publication date 01-08-2013

This site uses cookies

This website uses cookies to ensure you get the best experience on our website.